Analysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and/or cases with comorbidity

Cancer Chemotherapy and Pharmacology

Volumn 64, Issue 5, 2009, Pages 945-952

  Tsukuda, Mamoru ^a   Ishitoya, Junichi ^b   Mikami, Yasukazu ^a   Matsuda, Hideki ^a   Horiuchi, Choichi ^a   Taguchi, Takahide ^a   Satake, Kenichi ^a   Kawano, Toshiro ^b   Takahashi, Masahiro ^a   Nishimura, Goshi ^a   Kawakami, Mariko ^a   Sakuma, Yasunori ^b   Watanabe, Makiko ^a   Shiono, Osamu ^b   Komatsu, Masanori ^b   Yamashita, Yukiko ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Cases with comorbidity; Chemoradiotherapy; Elderly cases; S 1

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; ADVANCED CANCER; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; COMORBIDITY; DERMATITIS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEASIBILITY STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; LEUKOPENIA; MALE; MORNING DOSAGE; MUCOSA INFLAMMATION; NEUTROPENIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RASH; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; OXONIC ACID; SURVIVAL ANALYSIS; TEGAFUR; TREATMENT OUTCOME;

EID: 69049101977     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-0946-4     Document Type: Article

References (31)

1. EB Douple RC Richmond JA O'Hara CT Coughlin 1985 Carboplatin as a potentiator of radiation therapy Cancer Treat Rev 12 Suppl A 111 124
2. AA Forastiere H Goepfert M Maor TF Pajak R Weber W Morrison B Glisson A Trotti JA Ridge C Chao G Peters DJ Lee A Leaf J Ensley J Cooper 2003 Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2091 2098
3. EEW Cohen MW Lingen EE Vokes 2004 The expanding role of systemic therapy in head and neck cancer J Clin Oncol 22 1743 1752
4. SG Urba J Moon PG Shankar Giri DJ Adelstein E Hanna GH Yoo M LeBlanc JF Ensley DE Schuller 2005 Organ preservation for advanced respectable cancer of the base of tongue and hypopharynx: a southwest oncology group trial J Clin Oncol 23 88 95
5. M Fujii M Tsukuda B Satake A Kubota A Kida N Kohno K Okami Y Inuyama 2004 Phase I/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck Int J Clin Oncol 9 2 107 112
6. MR Posner DM Hershock CR Blajman E Mickiewicz E Winquist V Gorbounova S Tjulandin DM Shin K Cullen TJ Ervin BA Murphy LE Raez RB Cohen M Spaulding RB Tishler B Roth C Viroglio Rdel V Venkatesan I Romanov S Agarwala KW Harter M Dugan A Cmelak AM Markoe PW Read L Steinbrenner AD Colevas CM Norris Jr RI Haddad 2007 TAX 324 Study Group. Cisplatin, fluorouracil alone or with decetaxel in head, neck cancer N Engl J Med 357 17 1705 1715
7. TC Lo AJ Wiley FJ Ansfield JH Brandenburg HL Davis Jr FF Gollin RO Johnson G Ramirez H Vermund 1976 Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study Am J Roentgenol 126 229 235
8. JE Byfield P Calabro-Jones I Klisak F Kulhanian 1982 Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X-rays Int J Radiat Oncol Biol Phys 8 1923 1933
9. S Smalley B Kimler R Evans 1991 5-Fluorouracil modulation of radiosensitivity in cultured human carcinoma cells Int J Radiat Oncol Biol Phys 20 207 211
10. T Shirasaka Y Shimamoto H Ohshima M Yamaguchi T Kato K Yonekura M Fukushima 1996 Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potenciation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators Anticancer Drugs 7 548 557
11. T Shirasaka K Nakano T Takechi H Satake J Uchida A Fujioka H Saito H Okabe K Oyama S Takeda N Unemi M Fukushima 1996 Antitumor activity of 1M tegafur-0.4 M 5-chloro-2, 4-dihydoxypyridine-1M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats Cancer Res 56 2602 2606
12. P Schoffski 2004 The modulated oral fluropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors Anticancer Drugs 15 85 106
13. Y Inuyama A Kida M Tsukuda N Kohno B Satake 2001 Late phase II study of S-1 in patients with advanced head and neck cancer Gan To Kagaku Ryoho 28 1381 1390
14. M Tsukuda A Kida M Fujii N Kono T Yoshihara Y Hasegawa M Sugita Chemotherapy Study Group of Head, Neck Cancer 2005 Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer Br J Cancer 93 884 889
15. B Jeremic Y Shibamoto B Stanisavljevis L Milojevic B Milicic N Nikolic 1997 Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial Radiother Oncol 43 29 37
16. DJ Adelstein Y Li GL Adams H Wagner JA Kish JF Ensley DE Schuller AA Forastiere 2003 An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 92 98
17. RJ Bensadoun K Benezery O Dassonville N Magne G Poissonnet Lemanski C Ramaiolia S Bouldin J Tortochaux F Peyrade PY Nrasy E Chamorey J Vallicioni H Seng C Alzieu B Gery P Chauvel M Schneider J Santini F Demard G Calais 2006 French multicenter phase III randomized study testing concurrent twice-a day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: results at 2 years (FNCLCC-GORTEC) Int J Radiat Oncol Biol Phys 64 983 999
18. H Katori M Tsukuda T Taguchi 2007 Concurrent chemoradiotherapy with carboplatin and uracil-f tegafur (UFT) for patients with poor performance status with locally advanced squamous cell carcinoma of the head and neck (SCCHN) Acta Otolaryngol 127 1099 1104
19. H Koussis A Scola F Bergamo S Tonello U Basso P Karahontzitis V Chiarion-Sileni L Pasetto A Ruol L Loreggian O Lora R Bottin G Marioni M Donach A Jirillo 2008 Neoadjuvant carboplatin and vinorelbine followed by chemoradiotherapy in locally advanced head and neck or oesophageal squamous cell carcinoma: a phase II study in elderly patients with poor performance status Anticancer Res 28 1383 1388
20. TY Seiwert EEW Cohen 2005 State-of-the-art management of locally advanced head and neck cancer Br J Cancer 92 1341 1348
21. C Kosmas MS Kallistratos P Kopterides J Syrios H Skopelitis N Mylonakis A Karabelis N Tsavaris 2008 Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study J Cancer Res Clin Oncol 134 75 82
22. G Nishimura M Tsukuda C Horiuchi K Satake T Yoshida T Taguchi J Nagao M Kawakami N Kondo H Matsuda Y Mikami 2007 Decrease of creatinine clearance rate with aging in patients with head and neck cancer in Japan Int J Clin Oncol 12 120 124
23. H Katori M Tsukuda I Mochimatu J Ishitoya S Kawai Y Mikami H Matsuda Y Tanigaki C Horiuchi Y Ikeda T Taguchi M Ono T Yoshida S Hirose Y Sakuma K Yamamoto 2004 Phase 1 trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) Br J Cancer 90 348 352
24. T Taguchi M Tsukuda Y Mikami H Matsuda C Horiuchi T Yoshida G Nishimura J Ishitoya H Katori 2006 Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx Acta Otolaryngol 126 408 413
25. H Katori M Tsukuda T Taguchi 2007 Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck Cancer Chemother Pharmacol 59 789 794
26. K Hirata N Horikoshi K Aiba M Okazaki R Denno K Sasaki Y Nakano H Ishizuka Y Yamada S Uno T Taguchi T Shirasaka 1999 Phamacokinetic study of S-1, a novel oral fluorouracil antitumor drug Clin Cancer Res 5 2000 2005
27. Y Yamada T Hamaguchi M Goto K Muro Y Matsumura Y Shimada K Shirao S Nagayama 2003 Plasma concentrations of 5-fluorouracil and F-β-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenese inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil Br J Cancer 89 816 820
28. K Harada S Kawaguchi Kawashima Y Supriatno H Yoshida M Sato 2005 S-1, an oral fluoropyrimidine anti-cancer agent, enhanced radiosensitivity in a human oral cancer cell line in vivo and in vitro: involvement possibility of inhibition of survival signal, Akt/PKB Cancer Lett 226 161 168
29. E Nakata M Fukushima Y Takai K Nemoto Y Ogawa T Nomiya Y Nakamura L Milas S Yamada 2006 S-1, an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FU Oncol Rep 16 465 471
30. K Harada T Ferdous H Yoshida 2007 Investigation of optimal schedule of concurrent radiotherapy with S-1 for oral squamous cell carcinoma Oncol Rep 18 1077 1083
31. H Tsuji T Kiba M Nagata T Inoue H Yukawa T Yamashita Y Shimode H Murata K Nagata K Tomoda 2006 A phase I study of concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma Oncology 71 369 373